Diabetes Clinical Trials in Cleveland

Showing 221-240 of 517 trials

Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes

NCT01278823

The purpose of this study is to determine the effects of bariatric surgery on blood sugar control and underlying mechanisms that contribute to type 2 diabetes in men and women with a BMI between 27 and 42. Sixty subjects will be randomized to either undergo the roux-en-y gastric bypass operation or intensive medical, dietary and exercise management.

ObesityType 2 Diabetes

The Cleveland Clinic18 participantsStarted Jan 2011

Cleveland, Ohio, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

NCT01885208

This trial is conducted in Europe and North and South America. The aim of the trial is to investigate the efficacy and safety of semaglutide once-weekly versus exenatide ER (extended release) 2.0 mg once-weekly as add-on to 1-2 oral antidiabetic drugs (OADs) in subjects with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S813 participantsStarted Dec 2013

Anniston, Alabama, United States • Birmingham, Alabama, United States • Pell City, Alabama, United States +143 more locations

Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

Diabetes Trials in Other Cities

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

Other Conditions in Cleveland